Claris Biotherapeutics is based in Jersey City, New Jersey. It has raised $57M in total funding. Latest round: Series A.
Claris Biotherapeutics is based in Jersey City, New Jersey. Claris Biotherapeutics has raised $57M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2024. The round record for Claris Biotherapeutics runs through 2024; nothing later has been disclosed. Investors on record include Novo Holdings A/S, RA Capital Management, Mass General Brigham Ventures, Janus Henderson Investors. 4 distinct backers are named across the disclosed rounds.
We update the Claris Biotherapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Jersey City and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026